2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|
Revenue | $569K | $763K | $3.9M | $3.9M | $5.7M |
Cost of Revenue | $7.8M | $18M | $12M | $13M | $11M |
Gross Profit | -$7.2M | -$18M | -$7.9M | -$8.9M | -$5.1M |
Gross Profit % | -1.3K% | -2.3K% | -201% | -230% | -90% |
R&D Expenses | $8.8M | $9.5M | $17M | $20M | $16M |
2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|
Net Income | -$137M | -$145M | -$40M | -$72M | -$102M |
Dep. & Amort. | $235K | $1.8M | $3.7M | $4.8M | $5.2M |
Def. Tax | $98M | $93M | $0 | $0 | $0 |
Stock Comp. | $7.4M | $1.7M | $27M | $22M | $14M |
Chg. in WC | -$903K | -$14M | -$2.7M | $2.7M | $7M |
2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|
Cash | $8.7M | $100M | $47M | $82M | $39M |
ST Investments | $0 | $0 | $8.2M | $4M | $41M |
Cash & ST Inv. | $8.7M | $100M | $55M | $86M | $80M |
Receivables | $77K | $1.7M | $2.2M | $2.3M | $3.3M |
Inventory | $5M | $0 | $0 | $0 | $0 |
NN Group delivered strong 2024 results, with operating capital generation reaching €1.9 billion, meeting the 2025 target ahead of schedule; free cash flow rose 8% year-over-year to €1.5 billion, on track for the €1.6 billion 2025 target.
The group’s solvency ratio stands at 194%, at the upper end of its 150–200% comfort range, supported by management actions that offset market and regulatory headwinds; a further 3 percentage point uplift is expected from Basel IV implementation at NN Bank in 2025.
Commercial performance was robust: value of new business grew 20% year-over-year, driven by strong sales and margin improvements in Europe and higher defined benefit sales and pension buyouts in Netherlands Life; net inflow in Dutch defined contribution pensions was €2.3 billion, with AUM rising from €25 billion in 2020 to €39 billion in 2024.
NN continues its attractive capital return policy, announcing a full-year dividend of €3.44 per share (an 8% increase) and a recurring €300 million share buyback for 2024; management expects mid-single-digit dividend growth to be sustainable, amplified by buybacks.
Strategic asset allocation shifts (reducing equities and mortgages, increasing private debt and government bonds) are expected to be capital-neutral or slightly positive for Solvency II; about half of Netherlands Life’s longevity risk has been reinsured, with further deals possible depending on market conditions and pricing.